Return to content in this issue

 

Rituximab as a Single Agent for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immune Deficiency

Tessarin G1, Bondioni MP2, Rossi S1, Palumbo L3, Soresina A3, Badolato R1, Plebani A1, Lougaris V1

1Pediatrics Clinic, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy
2Pediatric Radiology, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy
3Pediatrics Clinic, ASST-Spedali Civili of Brescia, Brescia, Italy

J Investig Allergol Clin Immunol 2019; Vol 29(6) : 470-471
doi: 10.18176/jiaci.0450

Key words: Rituximab, Common variable immunodeficiency, Granulomatous lymphocytic interstitial lung disease, B cell, Tertiary lymphoid structures

Title Type Size
doi10.1876_jiaci.0450_material-suppl.pdf pdf 233.00 Kb